Pegylated insulin‐like growth factor‐1 biotherapeutic delivery promotes rotator cuff regeneration in a rat model

Tears in the rotator cuff are challenging to repair because of the complex, hypocellular, hypovascular, and movement‐active nature of the tendon and its enthesis. Insulin‐like Growth Factor‐1 (IGF‐1) is a promising therapeutic for this repair. However, its unstable nature, short half‐life, and abili...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomedical materials research. Part A Vol. 110; no. 7; pp. 1356 - 1371
Main Authors Prabhath, Anupama, Vernekar, Varadraj N., Esdaille, Caldon J., Eisenberg, Ellen, Lebaschi, Amir, Badon, Mary, Seyedsalehi, Amir, Dzidotor, Godwin, Tang, Xiaoyan, Dyment, Nathaniel, Thomopoulos, Stavros, Kumbar, Sangamesh G., Deymier, Alix, Weber, Eckhard, Laurencin, Cato T.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.07.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tears in the rotator cuff are challenging to repair because of the complex, hypocellular, hypovascular, and movement‐active nature of the tendon and its enthesis. Insulin‐like Growth Factor‐1 (IGF‐1) is a promising therapeutic for this repair. However, its unstable nature, short half‐life, and ability to disrupt homeostasis has limited its clinical translation. Pegylation has been shown to improve the stability and sustain IGF‐1 levels in the systemic circulation without disrupting homeostasis. To provide localized delivery of IGF‐1 in the repaired tendons, we encapsulated pegylated IGF‐1 mimic and its controls (unpegylated IGF‐1 mimic and recombinant human IGF‐1) in polycaprolactone‐based matrices and evaluated them in a pre‐clinical rodent model of rotator cuff repair. Pegylated‐IGF‐1 mimic delivery reestablished the characteristic tendon‐to‐bone enthesis structure and improved tendon tensile properties within 8 weeks of repair compared to controls, signifying the importance of pegylation in this complex tissue regeneration. These results demonstrate a simple and scalable biologic delivery technology alternative to tissue‐derived grafts for soft tissue repair.
Bibliography:Funding information
Anupama Prabhath and Varadraj N. Vernekar share co‐first authorship for this work.
NIH Pioneer, Grant/Award Number: 1DP1OD019349‐01; Novartis, Grant/Award Number: G600795; National Institute of Arthritis and Musculoskeletal and Skin Diseases Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant, Grant/Award Number: 1T32AR079114‐01
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1549-3296
1552-4965
DOI:10.1002/jbm.a.37378